ANIMAL HEALTH INTERNATIONAL, INC. Shares of Common Stock Underwriting AgreementUnderwriting Agreement • January 16th, 2007 • Animal Health International, Inc. • Wholesale-medical, dental & hospital equipment & supplies • New York
Contract Type FiledJanuary 16th, 2007 Company Industry JurisdictionAnimal Health International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule I hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of shares of common stock, par value $0.01 per share (the “Stock”), of the Company and certain stockholders of the Company named in Schedule II hereto (the “Selling Stockholders”) propose to sell to the Underwriters an aggregate of shares of Stock. In addition, at the option of the Underwriters, the Selling Stockholders propose to sell to the Underwriters an additional shares of Stock. The aggregate of shares of the Stock to be sold by the Company and the Selling Stockholders is herein called the “Underwritten Shares” and the aggregate of additional shares of Stock to be sold by the Selling Stockholders at the Underwriters’ option is herein called the “Option Shares”. The Underwritten Shares and the Option Shares are herein referre
OMNIVISION TECHNOLOGIES 3,125,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • June 27th, 2003 • Omnivision Technologies Inc • Semiconductors & related devices • New York
Contract Type FiledJune 27th, 2003 Company Industry JurisdictionOmniVision Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,000,000 shares, and, at the option of the Underwriters but solely to cover over-allotments, up to an additional 468,750 shares, of Common Stock, par value $0.001 per share (the “Stock”), of the Company, and the stockholders of the Company named in Schedule II hereto (the “Selling Stockholders”) propose to sell to the Underwriters an aggregate of 125,000 shares. The aggregate of 3,125,000 shares which may be sold by the Company and the Selling Stockholders is herein called the “Underwritten Shares” and the aggregate of 468,750 additional shares, which may be sold by the Company, is herein called the “Option Shares.” The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The Shares will have attached